colinz-laboratories-ltd

Home

Colinz Laboratories Ltd

Colinz Laboratories Ltd Financials

Colinz Laboratories Ltd Financial Statement

Colinz Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	1.94	1.81	1.74
Operating Expense	1.69	1.59	1.50
Net Profit	0.16	0.14	0.14
Net Profit Margin	8.25	7.73	8.05
Earning Per Share	0.62	0.54	0.54
EBIDTA	0.25	0.23	0.25
Effective Tax Rate	20	21.74	30.43

Particulars	Sep 2024
Revenue	1.94
Operating Expense	1.69
Net Profit	0.16
Net Profit Margin	8.25
Earning Per Share	0.62
EBIDTA	0.25
Effective Tax Rate	20.00

Colinz Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	7.03	7.15	6.97
Operating Expenses Annual	6.49	6.55	6.39
Operating Profit Annual	0.82	0.78	0.76
Interest Annual	0.04	0.05	0.08
Depreciation	0.13	0.13	0.20
Net Profit Annual	0.49	0.46	0.34
Tax Annual	0.16	0.14	0.14

Particulars	Mar 2024
Total Revenue Annual	7.03
Operating Expenses Annual	6.49
Operating Profit Annual	0.82
Interest Annual	0.04
Depreciation	0.13
Net Profit Annual	0.49
Tax Annual	0.16

Colinz Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	5.73	5.21	4.68
Cash Flow from Operations	1.03	0.40	0.47
Cash Flow from Investing	0.01	0.01	-0.03
Cash Flow from Financing	0.23	0.11	0.09
Cash Flow at the End	7	5.73	5.21

Particulars	Mar 2024
Cash Flow at the Beginning	5.73
Cash Flow from Operations	1.03
Cash Flow from Investing	0.01
Cash Flow from Financing	0.23
Cash Flow at the End	7

Colinz Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	11.66	10.91	10.90
PBIT Margin (%)	9.82	9.09	8.03
PBT Margin (%)	-235.56	-172.73	-92.40
Net PROFIT Margin (%)	6.97	6.43	4.88
Return On Networth / Equity (%)	5.73	5.81	4.54
Return On Networth /Employed (%)	7.70	7.82	6.78
Return On Assets (%)	5.44	5.53	4.10
Total Debt / Equity (X)	0.05	0.05	0.10
Asset Turnover Ratio (%)	0.78	0.86	0.84

Particulars	Mar 2024
PBDIT Margin (%)	11.66
PBIT Margin (%)	9.82
PBT Margin (%)	-235.56
Net PROFIT Margin (%)	6.97
Return On Networth / Equity (%)	5.73
Return On Networth /Employed (%)	7.70
Return On Assets (%)	5.44
Total Debt / Equity (X)	0.05
Asset Turnover Ratio (%)	0.78

Colinz Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	1.58	1.71	1.86
Total Current Assets Annual	8.74	7.84	7.38
Non Current Assets Annual	2.62	2.40	2.55
Total Shareholders Funds Annual	8.95	8.14	7.69
Total Assets Annual	11.36	10.23	9.93

Particulars	Mar 2024
Fixed Assets Annual	1.58
Total Current Assets Annual	8.74
Non Current Assets Annual	2.62
Total Shareholders Funds Annual	8.95
Total Assets Annual	11.36

Colinz Laboratories Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 11, 2024, Colinz Laboratories Ltd has a market capitalization of 17.16 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Colinz Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.06.

In FY 2023 , Colinz Laboratories Ltd recorded a total revenue of approximately 7.03 Cr marking a significant milestone in the company's financial performance.

Colinz Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.0% annually, respectively..

Colinz Laboratories Ltd's current PE ratio is 35.02.

Colinz Laboratories Ltd's ROCE averaged 7.2% from the FY ending March 2022 to 2024, with a median of 7.2%. It peaked at 7.8% in March 2023, reflecting strong capital efficiency over the period..

Colinz Laboratories Ltd's latest EBIT is Rs. 0.69 Cr, surpassing the average EBIT of Rs. 0.63 Cr over the 5 years..